CIBC Lowers Kinaxis (TSE:KXS) to Neutral

CIBC cut shares of Kinaxis (TSE:KXSFree Report) from an outperform rating to a neutral rating in a research note released on Friday, BayStreet.CA reports. CIBC currently has C$154.00 target price on the stock, down from their prior target price of C$180.00.

A number of other research analysts have also recently issued reports on the stock. Eight Capital decreased their price objective on shares of Kinaxis from C$230.00 to C$190.00 and set a buy rating for the company in a report on Friday, March 1st. Scotiabank cut their price target on shares of Kinaxis from C$220.00 to C$200.00 and set an outperform rating on the stock in a research note on Friday, March 1st. BMO Capital Markets cut their price target on shares of Kinaxis from C$190.00 to C$175.00 and set an outperform rating on the stock in a research note on Friday, March 1st. Royal Bank of Canada cut their price target on shares of Kinaxis from C$220.00 to C$200.00 and set an outperform rating on the stock in a research note on Friday, March 1st. Finally, Stifel Nicolaus cut their price target on shares of Kinaxis from C$235.00 to C$215.00 and set a buy rating on the stock in a research note on Friday, March 1st. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of Moderate Buy and a consensus target price of C$196.56.

Read Our Latest Stock Report on KXS

Kinaxis Trading Up 1.0 %

KXS opened at C$150.16 on Friday. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 11.91. The stock has a market capitalization of C$4.26 billion, a PE ratio of 208.56, a PEG ratio of 3.60 and a beta of 0.77. Kinaxis has a 1-year low of C$129.13 and a 1-year high of C$191.51. The firm has a 50-day moving average price of C$150.17 and a two-hundred day moving average price of C$152.02.

Kinaxis (TSE:KXSGet Free Report) last issued its quarterly earnings results on Wednesday, May 8th. The company reported C$0.36 EPS for the quarter, topping the consensus estimate of C$0.30 by C$0.06. Kinaxis had a net margin of 3.38% and a return on equity of 3.42%. The company had revenue of C$160.93 million during the quarter, compared to analysts’ expectations of C$158.33 million. As a group, equities analysts anticipate that Kinaxis will post 2.8913676 earnings per share for the current fiscal year.

Insider Transactions at Kinaxis

In related news, Senior Officer Stefanie Ann Gordish sold 214 shares of the business’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of C$150.24, for a total transaction of C$32,152.34. Following the transaction, the insider now directly owns 287 shares in the company, valued at C$43,120.20. In related news, Director J. Ian Giffen sold 2,500 shares of the business’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of C$145.75, for a total transaction of C$364,381.00. Also, Senior Officer Stefanie Ann Gordish sold 214 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of C$150.24, for a total transaction of C$32,152.34. Following the completion of the transaction, the insider now owns 287 shares in the company, valued at C$43,120.20. Insiders have sold a total of 34,650 shares of company stock valued at $5,253,452 over the last 90 days. 1.22% of the stock is owned by corporate insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.